Home
Valuation

Work Area: Valuation

Stealthy biotech buys up patent portfolios in string of recent deals

Terran Biosciences has emerged from obscurity to snap up slew of IP rights in the past two months

Dealing with 5G disappointment

The latest wireless standard hasn’t yet found its ‘killer app’ for consumers, and it’s affecting licensing negotiations

The advantages of using hedonic regression to measure the value of standardised technologies

Hedonic regression is a dependable and impartial way to estimate the value of a standardised technology. Further, it can be applied to a range of products, especially those with multiple features.

Latest content

How mapping IP and other intangibles can drive business value

The long read: Charting the value of intellectual assets can be difficult, writes Deloitte's Tim Heberden, but there are ways of showing their role as the drivers of revenue, efficiency and risk, and even in locating the value flows between them

14 April 2021

Six takeaways from the $1.8 billion finale to the LG Energy Solutions - SK Innovation IP dispute

As political wrangling and potential for commercial fallout mounted, the two Korean battery suppliers reached an eleventh-hour settlement deal yesterday

12 April 2021

Beware the flow of money into China’s transactions space

Saturday Opinion: Encouraging patent deals and lending through metrics and incentives could lay a trap for those who want a higher-quality patent system

03 April 2021

BlackBerry CEO: Majority of cash for patent portfolio expected in upfront payment

After IAM broke news of possible sale last year Canadian tech giant has confirmed it is in exclusive negotiations with a “North American” bidder for a part of its 38,000 asset stockpile

01 April 2021

IP analytics unicorn emerges with Softbank, Tencent backing

Singapore-based PatSnap says its latest round of fundraising pushed its valuation north of $1 billion

19 March 2021

Japanese government to weigh SEP licensing questions again

New group includes big names from the corporate IP world, representing Japanese stakeholders from both the auto and the electronics industries

17 March 2021

What life sciences businesses need to know about data commercialisation

A strategy for protecting and exploiting data is now a must for entities involved in healthcare research

25 February 2021

Seven top IP tips for biotech SMEs

How smaller biotechs can best overcome pitfalls and maximise the value of their inventions

18 February 2021

How an army of armchair investors showed why BlackBerry is seeking buyers for its 38,000 patents

The Canadian tech giant has built a licensing operation that brings in more than $300 million annually, but those gains have failed to shift shareholder sentiment

17 February 2021

Elite patent-owning companies enjoy three year run of stock success, new research reveals

A composite index of publicly-quoted entities with largest US portfolios has enjoyed strong performance since 2018

15 February 2021

Get unlimited access to all IAM content